Purchase Order 75N91020P00847
- Not listed
- The National Cancer Institute awarded a $24,995 firm fixed-price Blanket Purchase Agreement (BPA) call to Bio-Rad Laboratories, Inc.'s Life Science Group Division on September 14, 2016, for laboratory equipment and supplies. The contract was completed by October 7, 2016, with performance at the NCI facility in Bethesda, Maryland. This award was not designated as a small business set-aside, consistent with Bio-Rad's positioning as an established large federal contractor. The call was placed...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $24,995.00 by the National Cancer Institute on March 19, 2018, with performance completion scheduled for December 31, 2018. This contract was placed at the National Cancer Institute facility in Bethesda, Maryland, and was not designated as a small business set-aside. The award represents a call against Bio-Rad's broader procurement vehicle with the National Institutes of Health, through...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) valued at $4,671.90 on July 14, 2015, with a completion date of July 29, 2016. Awarded under a firm fixed-price contract type with no small business set-aside designation, this call order represents procurement activity under Bio-Rad's larger federal contracting relationship with the National Institutes of Health. The work was to be performed in...
- Bio-Rad Laboratories, Inc. was awarded a contract by the National Cancer Institute on March 27, 2014, with an ultimate completion date of April 19, 2015. This contract was executed as a Blanket Purchase Agreement (BPA) call under a fixed price redetermination pricing structure with a ceiling value of $1,133.06. The award was not designated as a small business set-aside. The work is to be performed in Bethesda, Maryland, and represents a call order against Bio-Rad's existing BPA vehicle with...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division received a Blanket Purchase Agreement (BPA) call order valued at $4,272 from the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health. This firm fixed-price contract, awarded on August 22, 2016, with an ultimate completion date of August 21, 2017, represents a task order placed against Bio-Rad's existing BPA vehicle. The work is to be performed at the NCI facilities in Bethesda, Maryland. This award...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a Blanket Purchase Agreement (BPA) call order valued at $3,292.81 by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health. This fixed-price redetermination contract, issued on November 25, 2013 with an ultimate completion date of November 28, 2014, was performed in Bethesda, Maryland. The award carried no small business set-aside designation, reflecting Bio-Rad's established position...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division received a $22,000 firm fixed-price Blanket Purchase Agreement (BPA) call order from the National Cancer Institute (NCI) on March 31, 2016, with an ultimate completion date of April 30, 2016. This contract was awarded without a small business set-aside designation. The work is to be performed at the NCI facility in Bethesda, Maryland. As a BPA call order, this award represents a specific procurement action executed under an existing...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a $25K firm fixed-price Blanket Purchase Agreement (BPA) call by the National Cancer Institute on July 11, 2022, for a real-time polymerase chain reaction (PCR) machine designed for detection of RNA expression. The equipment will be delivered to the National Cancer Institute's facility in Bethesda, Maryland, with an ultimate completion date of July 10, 2023. This contract award was not designated as a small business...
- Bio-Rad Laboratories, Inc. was awarded a Blanket Purchase Agreement (BPA) call contract valued at $3,916.00 by the National Cancer Institute (NCI), a component of the National Institutes of Health, with a performance location in Bethesda, Maryland. This firm fixed-price contract, awarded on October 31, 2014, with an ultimate completion date of November 30, 2015, represents a call order against Bio-Rad's broader purchasing agreement vehicle. The award carries no small business set-aside...
- Bio-Rad Laboratories, Inc. was awarded a $24,995 firm fixed-price BPA call by the National Cancer Institute on June 26, 2017, for laboratory equipment with an ultimate completion date of July 31, 2017. The contract was performed in Bethesda, Maryland and did not utilize a small business set-aside. Bio-Rad, a global leader in life science research and clinical diagnostics headquartered in Hercules, California, supplied specialized laboratory instrumentation through its Life Science Group...
The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $14,363.29 firm-fixed-price purchase order contract to Bio-Rad Laboratories, Inc. for a service contract to provide a Biorad Automated Droplet PCR System. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products. The company has established relationships with multiple federal agencies through prime contract awards, subcontracts, and grant sub-awards to provide specialized laboratory equipment, reagents, consumables, and services. This contract is not associated with any set-aside designations. Bio-Rad Laboratories, Inc. also holds a $1 billion Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations to facilitate the procurement of various biological materials, laboratory supplies, and other items in support of NIH research activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($6k) | 3/26/25 | |
| Not listed | Not listed | $20.2k | 8/31/20 |